The present invention provides vaccines for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a full-length, 5'-truncated or 3'-truncated 76 kDa protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.

 
Web www.patentalert.com

< Modified annexin compositions and methods of using same

> Pirfenidone treatment for patients with atypical liver function

> Synergistic antipyretic formulation

~ 00577